Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2019
Subject: Disclosure of Fourth Quarter and Fiscal Year 2018 financial results via press release (Exhibit 99.1).
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release. It does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for these metrics.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only indicates that such results were disclosed in the referenced press release.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on March 12, 2019, to disclose Q4 and full-year 2018 results.
Legal Status of Information: The press release and the information within Item 2.02 are furnished, not "filed," under Section 18 of the Exchange Act. They are not subject to liability under that section nor incorporated by reference into other filings unless expressly stated.
Guidance/Risks: No specific guidance, outlook, risks, or contingencies are detailed in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 12, 2019) for actual financial figures.
- Verify the specific revenue and net loss figures for Q4 and FY 2018 in the press release.
- Check for any updated guidance or operational milestones mentioned in the press release.
- Confirm the status of the Company's cash position and runway as detailed in the full press release.